SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Pluristem Therapeutics
An SI Board Since September 2005
Posts SubjectMarks Bans Symbol
295 17 0 PSTI
Emcee:  FJB Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
220Third Critically Ill Patient Successfully Treated With Pluristem's PLX Cellsxcentral119/5/2012
219And these folks seem to agree!! DS Brokerage sees 90 percent upside for Plurisxcentral119/5/2012
218A third similar case: maya.tase.co.ilidos-9/5/2012
217"Reacting in Sympathy?" ..(with all due respect) I'm thinking somexcentral119/4/2012
216PropThink: Interim Data In Spinal Cord Injury Driving STEM Higher; PSTI Reactingxcentral1-9/4/2012
215Pluristem Files for Orphan Drug Status With U.S. FDA for Use of PLX Cells in Trexcentral128/30/2012
214Pluristem Commences U.S. FDA Phase II Clinical Trial for Intermittent Claudicatixcentral128/23/2012
213Pluristem and World Renowned Charite Berlin-Brandenburg Center for Regenerative xcentral128/22/2012
212Pluristem Receives Approval From Indian Ministry of Health for Use of PLX Cells xcentral128/22/2012
211Equity Briefing: Pluristem partners with prestigious Institute for trial of multxcentral128/14/2012
210See - the product line is beginning to pop like corn! ~))xcentral1-8/13/2012
209Pluristem Moves Intermittent Claudication Indication Forward in Europe Through Cxcentral118/13/2012
208You're in the right place with PSTI.. I've known about their productxcentral1-8/13/2012
207Pluristem saved my Biotech Roulette Bankroll from evaporating into nothing. ThaFJB-8/9/2012
206Pluristem Receives Approval to Commence a Phase I/II Study for Muscle Regeneratixcentral118/7/2012
205Life of Cancer Patient Suffering From Bone Marrow Failure Saved Following Treatmxcentral128/6/2012
204Pluristem Therapeutics' New Indication for Pulmonary and Lung Disorders Expaxcentral127/31/2012
203U.S. National Institutes of Health to Support Development of Pluristem's PLXxcentral127/26/2012
202Maxim Initiates Coverage of Pluristem Therapeutics Inc. with a Buy Rating and $8xcentral127/25/2012
201Pluristem Therapeutics Set to Enter Bone Marrow Disease Market as it is Preparinxcentral127/24/2012
200Pluristem Therapeutics' Answer To Big Pharma's Question: What Do We Do NFJB17/18/2012
199HAIFA, Israel, July 18, 2012 (GLOBE NEWSWIRE) -- Pluristem Therapeutics, Inc. ( FJB-7/18/2012
198Pluristem's Unique Therapy Primed to Replace Blockbuster Drugs for Treating FJB17/11/2012
197Pluristem Pioneering Intramuscular Placenta-Based Cell Therapies July 3, 2012 FJB-7/4/2012
196Pluristem Therapeutics' Cell Therapy Broadens Addressable Markets - Demonstrxcentral126/19/2012
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News